Back
Apellis Pharmaceuticals Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
42
APLS
Apellis Pharmaceuticals
Last Price:
$33.33
Seasonality Move:
14.66%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is moderately bullish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Apellis Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.53 | Sell |
| 20-day SMA: | 33.82 | Sell |
| 50-day SMA: | 30.4 | Buy |
| 200-day SMA: | 38.96 | Sell |
| 8-day EMA: | 33.45 | Sell |
| 20-day EMA: | 33 | Buy |
| 50-day EMA: | 32.06 | Buy |
| 200-day EMA: | 38.37 | Sell |
Apellis Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.76 | Buy |
| Relative Strength Index (14 RSI): | 54.31 | Buy |
| Chaikin Money Flow: | 368815 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.9 - 34.98) | Buy |
| Bollinger Bands (100): | (28.2 - 37.06) | Buy |
Apellis Pharmaceuticals Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Apellis Pharmaceuticals Stock
Is Apellis Pharmaceuticals Stock a Buy?
-
Apellis Pharmaceuticals share price is 33.32 while APLS 8-day simple moving average is 33.53, which is a Sell signal.
-
The stock price of APLS is 33.32 while Apellis Pharmaceuticals 20-day SMA is 33.82, which makes it a Sell.
-
Apellis Pharmaceuticals 50-day simple moving average is 30.40 while APLS share price is 33.32, making it a Buy technically.
-
APLS stock price is 33.32 and Apellis Pharmaceuticals 200-day simple moving average is 38.96, creating a Sell signal.
APLS Technical Analysis vs Fundamental Analysis
Sell
42
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy or a Sell?
-
Apellis Pharmaceuticals stock is rated a SellThe current Apellis Pharmaceuticals [APLS] share price is $33.32. The Score for APLS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
Apellis Pharmaceuticals Stock Info
Market Cap:
4.1B
Price in USD:
33.32
Share Volume:
437.7K
Apellis Pharmaceuticals 52-Week Range
52-Week High:
73.80
52-Week Low:
24.34
Sell
42
Apellis Pharmaceuticals (APLS)
is a Sell
Apellis Pharmaceuticals Share Price Forecast
-
What is the Apellis Pharmaceuticals stock price today?The Apellis Pharmaceuticals stock price is 33.32 USD today.
-
Will APLS stock go up or go down?Apellis Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Apellis Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Apellis Pharmaceuticals is overvalued.
Is Apellis Pharmaceuticals Stock a Buy?
-
Apellis Pharmaceuticals share price is 33.32 while APLS 8-day exponential moving average is 33.45, which is a Sell signal.
-
The stock price of APLS is 33.32 while Apellis Pharmaceuticals 20-day EMA is 33.00, which makes it a Buy.
-
Apellis Pharmaceuticals 50-day exponential moving average is 32.06 while APLS share price is 33.32, making it a Buy technically.
-
APLS stock price is 33.32 and Apellis Pharmaceuticals 200-day simple moving average is 38.37, creating a Sell signal.
Fundamental Analysis of Apellis Pharmaceuticals
Is Apellis Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.77 per share, and an increase next year of $0.82 per share.
Technical Analysis of Apellis Pharmaceuticals
Should I short Apellis Pharmaceuticals stock?
-
APLS Moving Average Covergence Divergence (MACD) indicator is 0.76, suggesting Apellis Pharmaceuticals is a Buy
-
Apellis Pharmaceuticals Relative Strength Index (RSI) is 54.31, which suggest Apellis Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Apellis Pharmaceuticals is (30.9 - 34.98), which suggest Apellis Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Apellis Pharmaceuticals is (28.2 - 37.06), which suggest Apellis Pharmaceuticals is a Buy
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.